Komori
Treasury Stock5187CREATE MEDIC CO.,LTD.Electrical Equipment and Precision Instruments

Notice Regarding the Status of Share Repurchases

In July 2026, 35,300 shares were purchased on the market through the Tokyo Stock Exchange for a total acquisition cost of ¥40,066,400. Cumulative acquisitions since the resolution of the Board of Directors totaled 407,900 shares and ¥468,573,200.

Worth reading
48Recurring
Scored from 3 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
40066400
¥
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Market purchases on the Tokyo Stock Exchange

Resolved 27 March 2026 / Acquisition period 30 March 2026 to 31 October 2026

94.9%
Cumulative utilization rate
Limit
Number of Shares430,000 shares (maximum)
90.1%
Cumulative utilization rate
LimitShares 94.9%
Amount¥520,000,000 (maximum)

The darker band is the portion acquired this time (1 July 2026–31 July 2026). At this pace, the share-count limit will be reached first, and the acquisition will end without using the full monetary limit.

Number of Shares
Limit430,000 shares (maximum)
Cumulative total407,900 shares (through 31 July 2026)
Current35,300 shares
Amount
Limit¥520,000,000 (maximum)
Cumulative total¥468,573,200 (through 31 July 2026)
Current¥40,066,400
Average acquisition price for this transaction (calculated)¥1,135 per shareCurrent acquisition price ÷ current number of shares acquired

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction35,300 shares
Total current acquisition price¥40,066,400
Acquisition date/acquisition period1 July 2026–31 July 2026
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Cumulative number of shares acquired407,900 shares (through 31 July 2026)
Cumulative acquisition cost¥468,573,200 (through 31 July 2026)
Resolution date27 March 2026
Maximum number of shares to be acquired430,000 shares (maximum)
Total acquisition price¥520,000,000 (maximum)
Acquisition period under the resolution30 March 2026 to 31 October 2026
Items this document does not state (3)
Percentage of total issued sharesWhether acquisition has been completedAverage Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

No reason for the acquisition is provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Status of Share Repurchases | CREATE MEDIC CO.,LTD. (5187) timely disclosure | Komori